MULVIHILL; Mark J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for MULVIHILL; Mark J..The latest application filed is for "substituted spirocyclic inhibitors of autotaxin".

Company Profile

3.22.21

MULVIHILL; Mark J. - Waltham MA
Mulvihill; Mark J. - Concord MA
Mulvihill; Mark J. - Dix Hills NY US
Mulvihill; Mark J. - Melville NY US
Mulvihill; Mark J. - Farmingdale NY
Mulvihill; Mark J. - East Northport NY
Mulvihill; Mark J. - E. Northport NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Substituted Spirocyclic Inhibitors Of Autotaxin App 20190225611 - BABISS; Lee ; et al.	2019-07-25
Substituted spirocyclic inhibitors of autotaxin Grant 10,233,182 - Babiss , et al.	2019-03-19
Substituted Spirocyclic Inhibitors Of Autotaxin App 20180282332 - BABISS; Lee ; et al.	2018-10-04
Substituted spirocyclic inhibitors of autotaxin Grant 10,011,601 - Babiss , et al. July 3, 2	2018-07-03
Substituted Spirocyclic Inhibitors Of Autotaxin App 20170166568 - Babiss; Lee ; et al.	2017-06-15
Substituted N-(2-(amino)-2oxoethyl)benzamide Inhibitors Of Autotaxin And Their Preparation And Use In The Treatment Of Lpa-dependent Or Lpa-mediated Diseases App 20170037007 - Ruebsam; Frank ; et al.	2017-02-09
Substituted pteridinones for the treatment of cancer Grant 9,351,974 - Jin , et al. May 31, 2	2016-05-31
Dihydropteridinones App 20140315911 - Jin; Meizhong ; et al.	2014-10-23
6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors Grant 8,735,405 - Arnold , et al. May 27, 2	2014-05-27
Fused Bicyclic Kinase Inhibitors App 20140088114 - Jin; Meizhong ; et al.	2014-03-27
6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors Grant 8,653,268 - Mulvihill , et al. February 18, 2	2014-02-18
Substituted pyrrolo[2,3-b]-pyridines and -pyrazines Grant 8,592,448 - Chen , et al. November 26, 2	2013-11-26
Combination cancer therapy Grant 8,575,164 - Arnold , et al. November 5, 2	2013-11-05
Fused Bicyclic Kinase Inhibitors App 20130253197 - Mulvihill; Mark J. ; et al.	2013-09-26
6,6-Bicyclic Ring Substituted Heterobicyclic Protein Kinase Inhibitors App 20130190496 - Mulvihill; Mark J. ; et al.	2013-07-25
Substituted imidazopyr- and imidazotri-azines Grant 8,481,733 - Crew , et al. July 9, 2	2013-07-09
Fused bicyclic kinase inhibitors Grant 8,445,510 - Mulvihill , et al. May 21, 2	2013-05-21
Fused Bicyclic Kinase Inhibitors App 20130072495 - Li; An-Hu ; et al.	2013-03-21
7-aminofuropyridine derivatives Grant 8,378,104 - Hornberger , et al. February 19, 2	2013-02-19
6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors Grant 8,367,826 - Laufer , et al. February 5, 2	2013-02-05
Substituted-5-aminopyrrolo/pyrazolopyridines App 20120329826 - Li; An-Hu ; et al.	2012-12-27
Deuterated Tyrosine Kinase Inhibitors App 20120220595 - Epstein; David M. ; et al.	2012-08-30
2-aminopyridine kinase inhibitors Grant 8,178,668 - Steinig , et al. May 15, 2	2012-05-15
7-aminofuropyridine Derivatives App 20120046267 - Hornberger; Keith R. ; et al.	2012-02-23
6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors Grant 8,101,613 - Arnold , et al. January 24, 2	2012-01-24
Fused Bicyclic Kinase Inhibitors App 20110281888 - Mulvihill; Mark J. ; et al.	2011-11-17
Furo[3,2-C]pyridines Grant 8,022,206 - Li , et al. September 20, 2	2011-09-20
Substituted Pyrrolo[2,3-b]-Pyridines and -Pyrazines App 20110224191 - Chen; Xin ; et al.	2011-09-15
Imidazopyrazinol Derivatives For The Treatment Of Cancers App 20110046144 - Mulvihill; Mark J.	2011-02-24
6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors Grant 7,820,662 - Arnold , et al. October 26, 2	2010-10-26
Substituted Imidazopyr- And Imidazotri-azines App 20090286768 - Crew; Andrew P. ; et al.	2009-11-19
2-aminopyridine Kinase Inhibitors App 20090197862 - Steinig; Arno G. ; et al.	2009-08-06
Furo- and Thieno [3,2-c] Pyridines App 20090197864 - Li; An-Hu ; et al.	2009-08-06
Combination cancer therapy App 20080267957 - Arnold; Lee D. ; et al.	2008-10-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.